Rocket One Inc. Proceeds from Issuance of Private Placement
Rocket One Inc. (RKTO) reported Proceeds from Issuance of Private Placement of $701.48 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-05-15
- Rocket One Inc. proceeds from issuance of private placement for the quarter ending 2026-03-31 was $701.48K.
- Rocket One Inc. proceeds from issuance of private placement for fiscal 2025 was $4.29M, a 253.73% increase from fiscal 2024.
- Rocket One Inc. proceeds from issuance of private placement for fiscal 2024 was $1.21M.
| Period end | Proceeds from Issuance of Private Placement 0 month | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2026-03-31 | $701.48K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $4.29M 10-K · filed 2026-03-27 | |||
| 2024-12-31 | $1.21M 10-K · filed 2026-03-27 | |||
| 2021-01-05 | $4.60M 10-K · filed 2023-03-31 | $4.60M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |